Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension

This study will evaluate the safety and efficacy of once daily administered 0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution compared with once daily administered 0.03% Bimatoprost Ophthalmic Solution and once daily administered 0.5% Timolol Ophthalmic Solution concurrently in patients with open-angle glaucoma or ocular hypertension

Inclusion Criteria:

• Diagnosis of open-angle glaucoma or ocular hypertension in one or both eyes
• Eye pressure lowering topical medications are not working
• Visual acuity is at least 0.2 in each eye

Exclusion Criteria:

• Uncontrolled systemic disease
• Any other active eye disease other than glaucoma or ocular hypertension
• Significant visual field loss or evidence of progressive visual field loss within the last year
• Anticipated wearing of contact lenses during the study
• Required chronic use of other ocular medications during the study
• Eye surgery or laser treatment within 12 weeks prior to study enrollment